Novo Nordisk (NVO) is viewed as a compelling buy at its current price, as previous political risks have faded while its growth outlook remains strong. Key upcoming catalysts for NVO include its expansion into the India market and the potential development of an oral weight-loss pill. In contrast, Netflix (NFLX) is considered significantly overvalued and faces a major long-term threat from AI-generated content. Investors seeking a dominant tech leader may find better value in cheaper, faster-growing names like NVIDIA (NVDA) or Google (GOOGL). Duolingo (DUOL) is a stock to watch, but it only becomes a potential buying opportunity if its price falls by more than 30% from current levels.

Duolingo (DUOL)

• The speaker analyzes Duolingo after its stock price dropped significantly from a high of $530 to its current price of $199.
• The price drop is attributed to AI fears—the idea that AI will make language-learning apps obsolete.
• Valuation & Growth Metrics:
  • Enterprise Value / Gross Profit / Revenue Growth: 0.36. The speaker considers this "a little expensive, but not that expensive."
  • Rule of 40: 62 (considered strong).
  • EBITDA Margin: 29% (highly profitable).
  • Predicted Growth: 33%.
  • Daily Active User Growth: 36% year-over-year.
• Bullish View: The speaker believes the AI fears are overblown.
  • The app's core appeal is not just language learning, but its addictive, game-like nature that creates a "hook" for users, similar to a social media app or video game. The speaker calls it a "cigarette in disguise."
  • Because the value is in user engagement and addiction, AI is not a direct threat.
  • The business fundamentals remain strong, with "no hiccup" in growth despite the stock price fall.
  • The company has over 500 million downloads, making it a leading app.
• Bearish View / Risks:
  • The primary concern is the slow conversion of free users to paid subscribers. Paid subscriber penetration only grew from 8.5% to 9% year-over-year, which undermines the thesis that more users will pay for the service.
  • The company seems "stuck in language" and has not successfully expanded into other potential learning areas like math, music, or coding.
  • The speaker would only become interested if the valuation metric dropped below 0.2, which would require a further price drop of over 30%.

Takeaways

• Duolingo is viewed as a strong, growing, and profitable company whose stock has been punished by market fears about AI.
• The investment thesis hinges on whether you believe Duolingo is a utility for learning (threatened by AI) or an addictive game (less threatened by AI). The speaker leans towards the latter.
• A key risk to monitor is the company's ability to convert its massive user base into paying subscribers. The slow growth here is a significant red flag.
• The speaker considers the stock too expensive at current levels but would see it as a buying opportunity if the price were to fall significantly more.

Novo Nordisk (NVO)

• The speaker revisits Novo Nordisk, noting that their previous fears about geopolitical risks and US government action against the company were "unfounded."
• Despite the positive developments, the stock price has dropped significantly, which the speaker finds confusing and presents a potential opportunity.
• Valuation & Growth Metrics:
  • The speaker notes the stock is "much cheaper on a growth basis" than Duolingo.
  • Predicted Growth: 16%.
  • Gross Margin: 84%.
  • EBITDA Margin: 52%.
  • Rule of 40: 68 (very strong).
• Bullish View:
  • The company has mitigated political risk by investing $10 billion in the US and partnering with the government to lower drug prices. Manufacturing Ozempic in the USA reduces tariff risks.
  • It has a stable, recurring revenue business from its core diabetes drugs.
  • Its blockbuster weight-loss drugs, Wegovy and Ozempic, continue to perform well.
  • Future Catalysts:
    • Expansion into India: The speaker sees massive potential as Novo Nordisk's products enter the Indian market, which has tens of millions of overweight citizens.
    • Oral Medication: The development of an oral weight-loss pill (an expansion of the Rebelsius indication) would be a major catalyst, removing the barrier for people who have a fear of needles.

Takeaways

• The speaker is bullish on Novo Nordisk, calling the stock "pretty cheap" and "tempting" at its current valuation.
• The market may have unfairly punished the stock, as the major risks previously associated with it have not materialized.
• Investors are getting a stable, highly profitable company with massive growth drivers in its weight-loss drugs.
• Keep an eye on news related to the company's expansion into India and progress on an oral weight-loss pill, as these could be significant short-to-medium-term catalysts.

Netflix (NFLX)

• The speaker is highly critical of Netflix's valuation, calling it "super expensive" and "overhyped."
• Valuation & Growth Metrics:
  • Enterprise Value / Gross Profit / Revenue Growth: 1.39 (considered very high).
  • Rule of 40: 45 (good, but not exceptional for the price).
  • Trades at nearly 9 times sales and 33 times EBITDA.
  • Predicted Growth: 15%.
• Bearish View / Risks:
  • Extreme Valuation: The stock is significantly more expensive than other "uncontested leaders" like Google (GOOGL), NVIDIA (NVDA), and Meta (META), which are growing faster and are cheaper.
  • Risky Acquisition: A potential deal to buy Warner Brothers is viewed very negatively. The speaker points to AT&T's failed acquisition of the same company and warns of execution risk, culture clashes, and the need to issue new shares, which would reverse years of stock buybacks.
  • Major AI Threat: Unlike Duolingo, Netflix's core business of creating shows and movies is seen as highly vulnerable to disruption from AI-generated content. The speaker notes the rapidly improving quality of AI-generated short films and music.
  • Lack of Competitive Advantage in AI: Netflix does not have a clear edge in AI, especially since it relies on Amazon Web Services (AWS) for its infrastructure.
  • No Network Effect: The business lacks a strong network effect to protect its market position long-term.

Takeaways

• The speaker is very bearish on Netflix due to its sky-high valuation and significant long-term threats.
• The market is pricing Netflix for perfection, but it faces major risks from a potential ill-advised acquisition and, more fundamentally, from the rise of AI-generated entertainment.
• Investors looking for a dominant market leader might find better value and growth in other big tech names like NVIDIA or Google, which the speaker notes are cheaper.
• The stock is considered a poor risk/reward proposition at its current price.